These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6304572)

  • 1. [Anti-tissue autoantibodies in malignant pulmonary neoplasms].
    Ruffatti A; Visentin G; Giordano C; Bozzo R; De Silvestro G; Todesco S
    Minerva Med; 1983 May; 74(22-23):1319-24. PubMed ID: 6304572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity in the Lambert-Eaton myasthenic syndrome.
    Lennon VA; Lambert EH; Whittingham S; Fairbanks V
    Muscle Nerve; 1982; 5(9S):S21-5. PubMed ID: 6302494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
    Dropcho EJ; King PH
    Ann Neurol; 1994 Aug; 36(2):200-5. PubMed ID: 8053656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significantly higher frequencies of presence of serum autoantibodies in Chinese patients with oral lichen planus.
    Chang JY; Chiang CP; Hsiao CK; Sun A
    J Oral Pathol Med; 2009 Jan; 38(1):48-54. PubMed ID: 18764857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E rosettes in the uranium miners with lung cancer.
    Kudrna K; Andrlíková J; Smíd A; Stipl Z
    Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
    Vural B; Chen LC; Saip P; Chen YT; Ustuner Z; Gonen M; Simpson AJ; Old LJ; Ozbek U; Gure AO
    Cancer; 2005 Jun; 103(12):2575-83. PubMed ID: 15880380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.
    Bergqvist M; Brattström D; Larsson A; Hesselius P; Brodin O; Wagenius G
    BMC Cancer; 2004 Sep; 4():66. PubMed ID: 15367333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of auto-antibodies in the serum of Omani patients with gastric cancer.
    Al-Shukaili A; Al-Jabri AA; Al-Moundhri MS
    Saudi Med J; 2006 Dec; 27(12):1873-7. PubMed ID: 17143367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H; Seemayer NH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated immunoglobulins in pulmonary carcinoma.
    Gerstl B; Eng LF; Bigbee JW
    Cancer Res; 1977 Dec; 37(12):4449-55. PubMed ID: 200349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins and complement components levels in patients with lung cancer.
    Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
    Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue antibodies in a healthy New Zealand population.
    Bullock JY; Booth RJ; Wilson JD
    N Z Med J; 1979 Jan; 89(627):11-3. PubMed ID: 311908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The distribution of HLA-system antigens in lung cancer patients].
    Levin VI; Muravskaia GV; Buglova EE; Semenov GV; Shavlikova LA; Surovikina VV; Sinaĭko VV
    Vopr Onkol; 1991; 37(3):280-3. PubMed ID: 1851586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases].
    Oremek GM; Seiffert UB; Siekmeier R; Kirsten R
    Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
    Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.